This inventor holds 1 USPTO granted patent and 1 published patent application, plus 4 CIPO patents. Top assignee: Centro De Ingenieria Genetica Y Biotechnologia. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Gilberto Lazaro Pardo Andreu: Innovator in Neurodegenerative Disease Treatment
Introduction
Gilberto Lazaro Pardo Andreu is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative and ischemic brain diseases. His innovative work focuses on the medical applications of peptides and phycocyanobilin (PCB).
Latest Patents
Gilberto holds 1 patent for his invention titled "Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases." This patent describes peptides that include phycocyanobilin, highlighting their neuroprotective and neuroregenerative effects. The invention also discusses pharmaceutical combinations of these peptides and PCB with proteins or other peptides that have synergistic effects, justifying their use in treating central nervous system diseases.
Career Highlights
Gilberto is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he continues to advance research in biotechnology and pharmaceuticals. His work has the potential to significantly impact the treatment of various brain diseases, showcasing his dedication to improving healthcare outcomes.
Collaborations
He has collaborated with notable colleagues such as Gerardo Enrique Guillen Nieto and Alexis Musacchio Lasa, contributing to a dynamic research environment focused on innovative solutions in medicine.
Conclusion
Gilberto Lazaro Pardo Andreu's contributions to the field of neurodegenerative disease treatment through his patented inventions demonstrate his commitment to advancing medical science. His work is a testament to the importance of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile